Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors

BACKGROUND: Acquired resistance to endocrine therapy in breast cancer is poorly understood. Characterisation of the molecular response to aromatase inhibitors in breast cancer tissue may provide important information regarding development of oestrogen hypersensitivity. METHODS: We examined the expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Flågeng, M Hauglid, Haugan Moi, L L, Dixon, J M, Geisler, J, Lien, E A, Miller, W R, Lønning, P E, Mellgren, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768454/
https://www.ncbi.nlm.nih.gov/pubmed/19755984
http://dx.doi.org/10.1038/sj.bjc.6605324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768454/
https://www.ncbi.nlm.nih.gov/pubmed/19755984
http://dx.doi.org/10.1038/sj.bjc.6605324

Ejemplares similares